APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brigatinib Tablet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Brigatinib Tablet Market Outlook and Growth Opportunities 2026

20 December 2025191 pages

Choose your research edition.

Industry ResearchBrigatinib Tablet Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Brigatinib Tablet Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Brigatinib Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brigatinib Tablet Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Brigatinib Tablet Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Brigatinib Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Brigatinib Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Brigatinib Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brigatinib Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Brigatinib Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Brigatinib Tablet market include Takeda. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Brigatinib Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Brigatinib Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Brigatinib Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Brigatinib Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Brigatinib Tablet Segment by Company

Takeda

Brigatinib Tablet Segment by Type

30mg

50mg

180mg

Brigatinib Tablet Segment by Application

Hospital

Pharmacy

Brigatinib Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Brigatinib Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Brigatinib Tablet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Brigatinib Tablet significant trends, drivers, influence factors in global and regions.

6. To analyze Brigatinib Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brigatinib Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brigatinib Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brigatinib Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Brigatinib Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Brigatinib Tablet industry.

Chapter 3: Detailed analysis of Brigatinib Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Brigatinib Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Brigatinib Tablet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Brigatinib Tablet Industry Trends Table 2. Brigatinib Tablet Industry Drivers Table 3. Brigatinib Tablet Industry Opportunities and Challenges Table 4. Brigatinib Tablet Industry Restraints Table 5. Global Brigatinib Tablet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Brigatinib Tablet Revenue Share by Company (2021-2026) Table 7. Global Brigatinib Tablet Sales Volume by Company (k pcs) & (2021-2026) Table 8. Global Brigatinib Tablet Sales Volume Share by Company (2021-2026) Table 9. Global Brigatinib Tablet Average Price (US$/Pcs) of Company (2021-2026) Table 10. Global Brigatinib Tablet Company Ranking, (2024-2026) & (USD Million) Table 11. Global Brigatinib Tablet Key Company Manufacturing Base & Headquarters Table 12. Global Brigatinib Tablet Company, Product Type & Application Table 13. Global Brigatinib Tablet Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Brigatinib Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 30mg Table 18. Significant Companies of 50mg Table 19. Significant Companies of 180mg Table 20. Global Brigatinib Tablet Sales Volume by Type 2021 VS 2025 VS 2032 (k pcs) Table 21. Global Brigatinib Tablet Sales Volume by Type (2021-2026) & (k pcs) Table 22. Global Brigatinib Tablet Sales Volume by Type (2027-2032) & (k pcs) Table 23. Global Brigatinib Tablet Sales Volume Share by Type (2021-2026) Table 24. Global Brigatinib Tablet Sales Volume Share by Type (2027-2032) Table 25. Global Brigatinib Tablet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Brigatinib Tablet Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Brigatinib Tablet Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Brigatinib Tablet Sales Value Share by Type (2021-2026) Table 29. Global Brigatinib Tablet Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Table 32. Global Brigatinib Tablet Sales Volume by Application 2021 VS 2025 VS 2032 (k pcs) Table 33. Global Brigatinib Tablet Sales Volume by Application (2021-2026) & (k pcs) Table 34. Global Brigatinib Tablet Sales Volume by Application (2027-2032) & (k pcs) Table 35. Global Brigatinib Tablet Sales Volume Share by Application (2021-2026) Table 36. Global Brigatinib Tablet Sales Volume Share by Application (2027-2032) Table 37. Global Brigatinib Tablet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Brigatinib Tablet Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Brigatinib Tablet Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Brigatinib Tablet Sales Value Share by Application (2021-2026) Table 41. Global Brigatinib Tablet Sales Value Share by Application (2027-2032) Table 42. Global Brigatinib Tablet Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 43. Global Brigatinib Tablet Sales by Region (2021-2026) & (k pcs) Table 44. Global Brigatinib Tablet Sales Market Share by Region (2021-2026) Table 45. Global Brigatinib Tablet Sales by Region (2027-2032) & (k pcs) Table 46. Global Brigatinib Tablet Sales Market Share by Region (2027-2032) Table 47. Global Brigatinib Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Brigatinib Tablet Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Brigatinib Tablet Sales Value Share by Region (2021-2026) Table 50. Global Brigatinib Tablet Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Brigatinib Tablet Sales Value Share by Region (2027-2032) Table 52. Global Brigatinib Tablet Market Average Price (US$/Pcs) by Region (2021-2026) Table 53. Global Brigatinib Tablet Market Average Price (US$/Pcs) by Region (2027-2032) Table 54. Global Brigatinib Tablet Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Table 55. Global Brigatinib Tablet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Brigatinib Tablet Sales by Country (2021-2026) & (k pcs) Table 57. Global Brigatinib Tablet Sales Market Share by Country (2021-2026) Table 58. Global Brigatinib Tablet Sales by Country (2027-2032) & (k pcs) Table 59. Global Brigatinib Tablet Sales Market Share by Country (2027-2032) Table 60. Global Brigatinib Tablet Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Brigatinib Tablet Sales Value Market Share by Country (2021-2026) Table 62. Global Brigatinib Tablet Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Brigatinib Tablet Sales Value Market Share by Country (2027-2032) Table 64. Takeda Company Information Table 65. Takeda Business Overview Table 66. Takeda Brigatinib Tablet Sales (k pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 67. Takeda Brigatinib Tablet Product Portfolio Table 68. Takeda Recent Development Table 69. Key Raw Materials Table 70. Raw Materials Key Suppliers Table 71. Brigatinib Tablet Distributors List Table 72. Brigatinib Tablet Customers List Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Brigatinib Tablet Product Image Figure 2. Global Brigatinib Tablet Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brigatinib Tablet Sales Value (2021-2032) & (US$ Million) Figure 4. Global Brigatinib Tablet Sales (2021-2032) & (k pcs) Figure 5. Global Brigatinib Tablet Sales Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Brigatinib Tablet Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 30mg Image Figure 10. 50mg Image Figure 11. 180mg Image Figure 12. Global Brigatinib Tablet Sales Volume by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 13. Global Brigatinib Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Brigatinib Tablet Sales Volume Share by Type (2021-2032) Figure 15. Global Brigatinib Tablet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Brigatinib Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Brigatinib Tablet Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Global Brigatinib Tablet Sales Volume by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 21. Global Brigatinib Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Brigatinib Tablet Sales Volume Share by Application (2021-2032) Figure 23. Global Brigatinib Tablet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Brigatinib Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Brigatinib Tablet Sales Value Share by Application (2021-2032) Figure 26. Global Brigatinib Tablet Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 27. Global Brigatinib Tablet Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Brigatinib Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Brigatinib Tablet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Brigatinib Tablet Sales Value (2021-2032) & (US$ Million) Figure 31. North America Brigatinib Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Brigatinib Tablet Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Brigatinib Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Brigatinib Tablet Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Brigatinib Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Brigatinib Tablet Sales Value (2021-2032) & (US$ Million) Figure 37. South America Brigatinib Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Brigatinib Tablet Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Brigatinib Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Brigatinib Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Brigatinib Tablet Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Brigatinib Tablet Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 30mg
  • 50mg
  • 180mg
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Brigatinib Tablet Sales Value (2021-2032)
  4. 1.2.2 Global Brigatinib Tablet Sales Volume (2021-2032)
  5. 1.2.3 Global Brigatinib Tablet Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Brigatinib Tablet Market Dynamics
  1. 2.1 Brigatinib Tablet Industry Trends
  2. 2.2 Brigatinib Tablet Industry Drivers
  3. 2.3 Brigatinib Tablet Industry Opportunities and Challenges
  4. 2.4 Brigatinib Tablet Industry Restraints
3 Brigatinib Tablet Market by Company
  1. 3.1 Global Brigatinib Tablet Company Revenue Ranking in 2025
  2. 3.2 Global Brigatinib Tablet Revenue by Company (2021-2026)
  3. 3.3 Global Brigatinib Tablet Sales Volume by Company (2021-2026)
  4. 3.4 Global Brigatinib Tablet Average Price by Company (2021-2026)
  5. 3.5 Global Brigatinib Tablet Company Ranking (2024-2026)
  6. 3.6 Global Brigatinib Tablet Company Manufacturing Base and Headquarters
  7. 3.7 Global Brigatinib Tablet Company Product Type and Application
  8. 3.8 Global Brigatinib Tablet Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Brigatinib Tablet Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Brigatinib Tablet Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Brigatinib Tablet Market by Type
  1. 4.1 Brigatinib Tablet Type Introduction
  2. 4.1.1 30mg
  3. 4.1.2 50mg
  4. 4.1.3 180mg
  5. 4.2 Global Brigatinib Tablet Sales Volume by Type
  6. 4.2.1 Global Brigatinib Tablet Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Brigatinib Tablet Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Brigatinib Tablet Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Brigatinib Tablet Sales Value by Type
  10. 4.3.1 Global Brigatinib Tablet Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Brigatinib Tablet Sales Value by Type (2021-2032)
  12. 4.3.3 Global Brigatinib Tablet Sales Value Share by Type (2021-2032)
5 Brigatinib Tablet Market by Application
  1. 5.1 Brigatinib Tablet Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Brigatinib Tablet Sales Volume by Application
  5. 5.2.1 Global Brigatinib Tablet Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Brigatinib Tablet Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Brigatinib Tablet Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Brigatinib Tablet Sales Value by Application
  9. 5.3.1 Global Brigatinib Tablet Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Brigatinib Tablet Sales Value by Application (2021-2032)
  11. 5.3.3 Global Brigatinib Tablet Sales Value Share by Application (2021-2032)
6 Brigatinib Tablet Regional Sales and Value Analysis
  1. 6.1 Global Brigatinib Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Brigatinib Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Brigatinib Tablet Sales by Region: 2021-2026
  4. 6.2.2 Global Brigatinib Tablet Sales by Region (2027-2032)
  5. 6.3 Global Brigatinib Tablet Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Brigatinib Tablet Sales Value by Region (2021-2032)
  7. 6.4.1 Global Brigatinib Tablet Sales Value by Region: 2021-2026
  8. 6.4.2 Global Brigatinib Tablet Sales Value by Region (2027-2032)
  9. 6.5 Global Brigatinib Tablet Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Brigatinib Tablet Sales Value (2021-2032)
  12. 6.6.2 North America Brigatinib Tablet Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Brigatinib Tablet Sales Value (2021-2032)
  15. 6.7.2 Europe Brigatinib Tablet Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Brigatinib Tablet Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Brigatinib Tablet Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Brigatinib Tablet Sales Value (2021-2032)
  21. 6.9.2 South America Brigatinib Tablet Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Brigatinib Tablet Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Brigatinib Tablet Sales Value Share by Country, 2025 VS 2032
7 Brigatinib Tablet Country-level Sales and Value Analysis
  1. 7.1 Global Brigatinib Tablet Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Brigatinib Tablet Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Brigatinib Tablet Sales by Country (2021-2032)
  4. 7.3.1 Global Brigatinib Tablet Sales by Country (2021-2026)
  5. 7.3.2 Global Brigatinib Tablet Sales by Country (2027-2032)
  6. 7.4 Global Brigatinib Tablet Sales Value by Country (2021-2032)
  7. 7.4.1 Global Brigatinib Tablet Sales Value by Country (2021-2026)
  8. 7.4.2 Global Brigatinib Tablet Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Brigatinib Tablet Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Brigatinib Tablet Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Brigatinib Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Brigatinib Tablet Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Brigatinib Tablet Product Portfolio
  6. 8.1.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Brigatinib Tablet Value Chain Analysis
  2. 9.1.1 Brigatinib Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Brigatinib Tablet Sales Mode & Process
  6. 9.2 Brigatinib Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Brigatinib Tablet Distributors
  9. 9.2.3 Brigatinib Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst